Suppr超能文献

术前肥胖症患者非酒精性脂肪性肝炎的检测:声辐射力脉冲成像的初步评估。

Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging.

机构信息

Department of of Radiology, Virgen de la Arrixaca University Hospital, 30120, El Palmar, Murcia, Spain.

出版信息

Eur Radiol. 2012 Nov;22(11):2525-32. doi: 10.1007/s00330-012-2505-3. Epub 2012 Jun 1.

Abstract

OBJECTIVE

To investigate the utility of acoustic radiation force impulse (ARFI) imaging, with the determination of shear wave velocity (SWV), to differentiate non-alcoholic fatty liver disease (NAFLD) from non-alcoholic steatohepatitis (NASH) in patients with morbid obesity before bariatric surgery.

METHODS

Thirty-two patients with morbid obesity were evaluated with ARFI and conventional ultrasound before bariatric surgery. The ARFI and ultrasound results were compared with liver biopsy findings, which is the reference standard. The patients were classed according to their histological findings into three groups: group A, simple steatosis; group B, inflammation; and group C, fibrosis.

RESULTS

The median SWV was 1.57 ± 0.79 m/s. Hepatic alterations were observed in the histopathological findings for all the patients in the study (100 %), with the results of the laboratory tests proving normal. Differences in SWV were also observed between groups A, B and C: 1.34 ± 0.90 m/s, 1.55 ± 0.79 m/s and 1.86 ± 0.75 m/s (P < 0.001), respectively. The Az for differentiating NAFLD from NASH or fibrosis was 0.899 (optimal cut-off value 1.3 m/s; sensitivity 85 %; specificity 83.3 %).

CONCLUSION

The ARFI technique is a useful diagnostic tool for differentiating NAFLD from NASH in asymptomatic patients with morbid obesity.

KEY POINTS

• Acoustic radiation force impulse imaging provides ultrasonic shear wave velocity measurements. • SWV measurements were higher in patients with inflammation or fibrosis than NAFLD. • ARFI differentiates NAFLD from NASH in patients with morbid obesity. • Results suggest that ARFI can detect NASH in asymptomatic morbidly obese patients.

摘要

目的

探讨声辐射力脉冲(ARFI)成像技术,通过测定剪切波速度(SWV),在肥胖症患者行减重手术前,鉴别非酒精性脂肪性肝病(NAFLD)与非酒精性脂肪性肝炎(NASH)。

方法

32 例病态肥胖症患者在减重手术前行 ARFI 和常规超声检查。将 ARFI 和超声结果与肝活检结果进行比较,后者为参考标准。根据组织学发现,患者分为三组:A 组单纯脂肪变性;B 组炎症;C 组纤维化。

结果

SWV 的中位数为 1.57±0.79m/s。所有患者的组织病理学检查均发现肝组织改变(100%),实验室检查结果正常。组 A、B 和 C 之间的 SWV 也存在差异:1.34±0.90m/s、1.55±0.79m/s 和 1.86±0.75m/s(P<0.001)。鉴别 NAFLD 与 NASH 或纤维化的 Az 值为 0.899(最佳截断值 1.3m/s;敏感性 85%;特异性 83.3%)。

结论

ARFI 技术是一种有用的诊断工具,可用于鉴别无症状肥胖症患者的 NAFLD 与 NASH。

关键点

• ARFI 成像技术提供超声剪切波速度测量。

• 炎症或纤维化患者的 SWV 测量值高于单纯脂肪变性患者。

• ARFI 可鉴别病态肥胖患者的 NAFLD 与 NASH。

• 结果表明 ARFI 可在无症状肥胖患者中检测到 NASH。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验